To add to that taken from @Sam_123 post https://hotcopper.com.au/posts/49657665/single
SI makes reference to this exact possibility.
It’s these data where Mesoblast now sees a potential path ahead. Itescu further told investors in Monday’s call that rexlemestrocel-L could prove a complementary medicine to drugs that reduce hospitalizations but don’t reduce mortality.He also said in previous meetings with the FDA that the agency has made clear it is focusing on mortality, despite hospitalization serving as primary.
Ann: Trading halt, page-638
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |